Reduced Intensity Conditioning for Allogeneic Stem Cell Transplantation (HSCT) in Acute Myeloid Leukemia
Allogeneic transplantation (HSCT) is an effective curative therapy for high risk acute myeloid leukemia (AML) which account for 38% of the transplants in Europe (1). Prior to HSCT, a conditioning or preparative regimen is administered. The conditioning regimen has 2 components; one target the myeloi...
Main Author: | Arnon Nagler |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137922013165 |
Similar Items
-
Reduced Intensity versus Full Myeloablative Conditioning in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
by: Kamran Alimoghaddam, et al.
Published: (2011-09-01) -
Allogeneic stem cell transplantation in acute myeloid leukemia
by: Natasha Ali, et al.
Published: (2012-11-01) -
PB2450: SEX-ASSOCIATED OUTCOME DIFFERENCES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
by: Jule Ussmann, et al.
Published: (2023-08-01) -
PB2407: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) WITH CYCLOPHOSPHAMIDE IN PEDIATRIC HIGH-RISK ACUTE MYELOID LEUKEMIA (HR-AML)
by: Ming Sun, et al.
Published: (2023-08-01) -
PEDIATRIC ACUTE PROMYELOCYTIC LEUKEMIA HAS EXCELLENT RESULTS WITH AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
by: ACRD Bronzoni, et al.
Published: (2023-10-01)